Table 1

Eligibility criteria for inclusion

Study selectionThis systematic review and meta-analysis includes only RCTs published in English language from inception till the end of study period. Hybrid studies, cross over trial, observational studies and case series were excluded.
ParticipantsAdult population (18 years or older) diagnosed with at least one cardiac disease and referred for cardiac rehabilitation programme using VR (fully immersive or non-immersive). Cardiac diseases include but are not limited to ischaemic heart disease, non-ischaemic cardiomyopathy, heart failure and valvular heart disease.
InterventionPatients participate in cardiac rehabilitation with some form of virtual reality devices during training sessions. These devices may be immersive (user interacts within a three-dimensional world generated by software) or non-immersive (user interacts with a two-dimensional environment generated by a software via screen such as a computer screen or a TV screen etc).
ComparatorPatients participate in cardiac rehabilitation training sessions under supervision of a cardiac rehabilitation professional at a hospital or a cardiac rehabilitation centre or at home.
OutcomesAnxiety assessed using standardised questionnaires like HADS-A and STAI. Physical activity assessed as FC measured in PVO2.
  • FC, functional capacity; HADS-A, Hospital Anxiety and Depression Scale; PVO2, peak oxygen uptake; RCT, randomised controlled trial; STAI, State Trait Anxiety Inventory; VR, virtual reality.